[1] Patterns of histone acetylation.
Thorne AW, Kmiciek D, Mitchelson K, Sautiere P, Crane-Robinson C.
Eur J Biochem. 1990 Nov 13;193(3):701-13. [
PMID: 2249688]
[2] Organismal differences in post-translational modifications in histones H3 and H4.
Garcia BA, Hake SB, Diaz RL, Kauer M, Morris SA, Recht J, Shabanowitz J, Mishra N, Strahl BD, Allis CD, Hunt DF.
J Biol Chem. 2007 Mar 9;282(10):7641-55. [
PMID: 17194708]
[3] Update on activities at the Universal Protein Resource (UniProt) in 2013.
e="String">UniProt Consortium.
Nucleic Acids Res. 2013 Jan;41(Database issue):D43-7. [
PMID: 23161681]
[4] Screen for DNA-damage-responsive histone modifications identifies H3K9Ac and H3K56Ac in human cells.
Tjeertes JV, Miller KM, Jackson SP.
EMBO J. 2009 Jul 8;28(13):1878-89. [
PMID: 19407812]
[5] Overlapping but distinct patterns of histone acetylation by the human coactivators p300 and PCAF within nucleosomal substrates.
Schiltz RL, Mizzen CA, Vassilev A, Cook RG, Allis CD, Nakatani Y.
J Biol Chem. 1999 Jan 15;274(3):1189-92. [
PMID: 9880483]
[6] Tip60 acetylates six lysines of a specific class in core histones in vitro.
Kimura A, Horikoshi M.
Genes Cells. 1998 Dec;3(12):789-800. [
PMID: 10096020]
[7] Elongator is a histone H3 and H4 acetyltransferase important for normal histone acetylation levels in vivo.
Winkler GS, Kristjuhan A, Erdjument-Bromage H, Tempst P, Svejstrup JQ.
Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3517-22. [
PMID: 11904415]
[8] Analysis of dynamic changes in post-translational modifications of human histones during cell cycle by mass spectrometry.
Bonenfant D, Towbin H, Coulot M, Schindler P, Mueller DR, van Oostrum J.
Mol Cell Proteomics. 2007 Nov;6(11):1917-32. [
PMID: 17644761]
[9] A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles.
Wagner SA, Beli P, Weinert BT, Nielsen ML, Cox J, Mann M, Choudhary C.
Mol Cell Proteomics. 2011 Oct;10(10):M111.013284. [
PMID: 21890473]
[10] Methods for quantification of in vivo changes in protein ubiquitination following proteasome and deubiquitinase inhibition.
Udeshi ND, Mani DR, Eisenhaure T, Mertins P, Jaffe JD, Clauser KR, Hacohen N, Carr SA.
Mol Cell Proteomics. 2012 May;11(5):148-59. [
PMID: 22505724]
[11] Landscape of the PARKIN-dependent ubiquitylome in response to mitochondrial depolarization.
Sarraf SA, Raman M, Guarani-Pereira V, Sowa ME, Huttlin EL, Gygi SP, Harper JW.
Nature. 2013 Apr 18;496(7445):372-6. [
PMID: 23503661]
[12] Targeted identification of SUMOylation sites in human proteins using affinity enrichment and paralog-specific reporter ions.
Lamoliatte F, Bonneil E, Durette C, Caron-Lizotte O, Wildemann D, Zerweck J, Wenschuh H, Thibault P.
Mol Cell Proteomics. 2013 Jun 7;. [
PMID: 23750026]
[13] Substrate and functional diversity of lysine acetylation revealed by a proteomics survey.
Kim SC, Sprung R, Chen Y, Xu Y, Ball H, Pei J, Cheng T, Kho Y, Xiao H, Xiao L, Grishin NV, White M, Yang XJ, Zhao Y.
Mol Cell. 2006 Aug;23(4):607-18. [
PMID: 16916647]
[14] Lysine acetylation targets protein complexes and co-regulates major cellular functions.
Choudhary C, Kumar C, Gnad F, Nielsen ML, Rehman M, Walther TC, Olsen JV, Mann M.
Science. 2009 Aug 14;325(5942):834-40. [
PMID: 19608861]
[15] Systematic and quantitative assessment of the ubiquitin-modified proteome.
Kim W, Bennett EJ, Huttlin EL, Guo A, Li J, Possemato A, Sowa ME, Rad R, Rush J, Comb MJ, Harper JW, Gygi SP.
Mol Cell. 2011 Oct 21;44(2):325-40. [
PMID: 21906983]
[16] Proteomic analyses reveal divergent ubiquitylation site patterns in murine tissues.
Wagner SA, Beli P, Weinert BT, Schölz C, Kelstrup CD, Young C, Nielsen ML, Olsen JV, Brakebusch C, Choudhary C.
Mol Cell Proteomics. 2012 Dec;11(12):1578-85. [
PMID: 22790023]
[17] Refined preparation and use of anti-diglycine remnant (K-ε-GG) antibody enables routine quantification of 10,000s of ubiquitination sites in single proteomics experiments.
Udeshi ND, Svinkina T, Mertins P, Kuhn E, Mani DR, Qiao JW, Carr SA.
Mol Cell Proteomics. 2013 Mar;12(3):825-31. [
PMID: 23266961]
[18] The type III histone deacetylase Sirt1 protein suppresses p300-mediated histone H3 lysine 56 acetylation at Bclaf1 promoter to inhibit T cell activation.
Kong S, Kim SJ, Sandal B, Lee SM, Gao B, Zhang DD, Fang D.
J Biol Chem. 2011 May 13;286(19):16967-75. [
PMID: 21454709]